Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken. (Q37084269)

From Wikidata

Jump to navigation Jump to search

scientific article published on 14 February 2008

edit

Language	Label	Description	Also known as
English	Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken.	scientific article published on 14 February 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

review article

1 reference

stated in

Europe PubMed Central

title

Mechanisms of action and resistance of somatostatin analogues for the treatment of hepatocellular carcinoma: a message not well taken (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

main subject

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author

George Notas

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

author name string

Dimitrios N Samonakis

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

Nikolaos Christodoulakis

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

Elias A Kouroumalis

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

publication date

14 February 2008

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

published in

Digestive Diseases and Sciences

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

volume

53

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

page(s)

2359-2365

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

cites work

Long acting octreotide in the treatment of advanced hepatocellular cancer and overexpression of somatostatin receptors: randomized placebo-controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1007%2FS10620-007-0175-9

retrieved

21 January 2018

Hepatocellular carcinoma: present status and future prospects

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide inhibits proliferation and induces apoptosis of hepatocellular carcinoma cells.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful treatment of an advanced hepatocellular carcinoma with the long-acting somatostatin analog lanreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oncological applications of somatostatin analogues

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of somatostatin analogs in the control of tumor growth.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide regulates CC but not CXC LPS-induced chemokine secretion in rat Kupffer cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotype

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary liver cancer: worldwide incidence and trends

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulatory peptide receptors in human hepatocellular carcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular pathogenesis of human hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide therapy for advanced hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation and function of somatostatin receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The inhibitory effect of opioids on HepG2 cells is mediated via interaction with somatostatin receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potent induction of apoptosis in human hepatoma cell lines by targeted cytotoxic somatostatin analogue AN-238.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dissociation of antiproliferative and antihormonal effects of the somatostatin analog octreotide on 7315b pituitary tumor cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide for unresectable hepatocellular carcinoma: beyond the first sight

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Liver transplantation in patients with hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide treatment of hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatocellular carcinoma with long acting somatostatin analogues.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogs in the diagnosis and treatment of cancer

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting octreotide versus placebo for treatment of advanced HCC: a randomized controlled double-blind study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: natural history and prognostic prediction of patients with hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A possible role for insulin-like growth factor-binding protein-3 autocrine/paracrine loops in controlling hepatocellular carcinoma cell proliferation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: current surgical management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptors as molecular targets for cancer diagnosis and therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma: the need for progress.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signal transduction of somatostatin receptors negatively controlling cell proliferation.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of octreotide on apoptosis-related proteins in rat Kupffer cells: a possible anti-tumour mechanism.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Complete regression of advanced HCC with long acting octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cortistatin production by HepG2 human hepatocellular carcinoma cell line and distribution of somatostatin receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin and its receptor family

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential expression of somatostatin receptor subtypes in hepatocellular carcinomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiological consequences of somatostatin receptor internalization and resistance

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A dramatic response to long-acting octreotide in metastatic hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor subtype 2 and 5 in human GH-secreting pituitary adenomas: analysis of gene sequence and mRNA expression.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptors and regulation of cell proliferation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy for unresectable hepatocellular carcinoma: review of the randomized clinical trials-II: systemic and local non-embolization-based therapies in unresectable and advanced hepatocellular carcinoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of sandostatin LAR in treating patients with advanced hepatocellular cancer.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of inflammatory mediators by isolated rat Kupffer cells: the effect of octreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment outcomes with long acting octreotide in inoperable hepatocellular carcinoma: a local experience and review of literature.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Review article: hepatocellular carcinoma: indications for liver transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18273705

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S10620-007-0175-9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

PubMed publication ID

18273705

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18273705

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18273705%20AND%20SRC:MED&resulttype=core&format=json

retrieved

2 January 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37084269&oldid=2199849339"